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Mimicking the structural organization and biologic function of natural extracellular matrix has been one of the
main goals of tissue engineering. Nevertheless, the majority of scaffolding materials for bone regeneration
highlights biochemical functionality in detriment of mechanical properties. In this work we present a rather
innovative construct that combines in the same structure electrospun type I collagen nanofibers with starch-
based microfibers. These combined structures were obtained by a two-step methodology and structurally consist
in a type I collagen nano-network incorporated on a macro starch-based support. The morphology of the
developed structures was assessed by several microscopy techniques and the collagenous nature of the nano-
network was confirmed by immunohistochemistry. In addition, and especially regarding the requirements of
large bone defects, we also successfully introduced the concept of layer by layer, as a way to produce thicker
structures. In an attempt to recreate bone microenvironment, the design and biochemical composition of the
combined structures also envisioned bone-forming cells and endothelial cells (ECs). The inclusion of a type I
collagen nano-network induced a stretched morphology and improved the metabolic activity of osteoblasts.
Regarding ECs, the presence of type I collagen on the combined structures provided adhesive support and
obviated the need of precoating with fibronectin. It was also importantly observed that ECs on the nano-network
organized into circular structures, a three-dimensional arrangement distinct from that observed for osteoblasts
and resembling the microcappillary-like organizations formed during angiogenesis. By providing simulta-
neously physical and chemical cues for cells, the herein-proposed combined structures hold a great potential in
bone regeneration as a man-made equivalent of extracellular matrix.
Introduction
In bone tissue engineering, the material selection lies atthe very heart of the scaffold design. Up to date, various
alternatives, such as metals, ceramics, and polymers, have
been proposed to be used as scaffold materials. However,
nowadays scaffolds are typically fashioned from biode-
gradable materials of natural origin proteins like collagen1
and silk fibroin,2 and polymers like chitosan,3 starch,4 and
poly(3-hydroxybutyrate),5 and also from synthetic polymers
such as poly(lactide),6 poly(lactide/glycolide),7 and poly-
caprolactone.8 Although synthetic polymers appear to be a
good choice regarding processing, critical problems in bio-
compatibility, degradation products, and numerous other
issues still remain to be solved. Conversely, naturally de-
rived materials offer some advantages in terms of biocom-
patibility, as well as biochemical functionality by showing
similarity to structures in animal tissues. The use of collagen
as a scaffold is distinct from other polymers mainly due to
its role in the formation of tissue and organs. It is the most
abundant mammalian protein accounting for about 20%–
30% of total body proteins.9 Collagen assembles into dif-
ferent supramolecular structures in natural extracellular
matrix (ECM) of tissues and has exceptional functional
diversity.
ECM is a complex composite of various proteins in
fibrillar form and glycosaminoglycans chains10 and provides
an important model for scaffold design. This network
structure serves as a scaffold that can support tensile and
compressive stresses by the fibrils and hydrated networks.
Besides providing an appropriate microenvironment for
cells, ECM is responsible for transmitting signals to cell
membrane receptors that reach nucleus via intracellular
signaling cascades. Therefore, the fibrillar and porous
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structure of ECM has a great influence on cell functionality,
mainly on cell adhesion and migration.
The development of suitable scaffolds, man-made systems
that can mimic the structural organization and biologic
function of natural ECM, remains a major aim for tissue
engineers. In recent years, the electrospinning processes have
received substantial attention as a way to mimic the structure
of natural ECM by means of producing fibers down to
3 nm.11 This is due to the architectural similarity of the
nonwoven mats, composed of electrospun nanofibers, to
collagen structure of ECM. However, the pore sizes of elec-
trospun mats, which are smaller than a cellular diameter,
cannot allow for cell migration within the structure and
results in a scaffold surface covered by a film of cells. Such
type of systems cannot be used for tissue engineering of
three-dimensional (3D) tissues. Further, the small size of the
fibers tends not to maximize the points of cell attachment,
which is a negative effect on expression of several factors and
on cell spreading and differentiation.
When engineering bone, the scaffold must meet the me-
chanical properties of the tissue while it should also ideally
mimic the biological task of ECM. Bone tissue is composed of
a heterogeneous mixture of cell types embedded within a
mineralized ECM.12 To assure the requirements of this met-
abolic active tissue, bone microenvironment is supplied by a
complex intraosseous circulation composed by an intricate
network of arteries, capillaries, and veins.13 Type I collagen is
the major organic component of the osseous ECM. Besides its
structural role, this ECM protein also promotes cell adhesion
in an integrin-mediated fashion.14 In addition, type I collagen
modulates cell-specific functions. In the osteogenic lineage it
promotes osteogenic differentiation, proliferation, and min-
eralization.12,15 Endothelial cells (ECs) are pivotal cells in
blood vessel formation, and it is known that interstitial type I
collagen induces the directional migration and lumen for-
mation during angiogenesis.16,17 In fact osteogenesis and
angiogenesis are two phenomena that cannot be dissociated
during skeletal development, fracture repair, as well as in
bone tissue engineering.18 It is well known that prompt
revascularization favors osteoblastic differentiation, whereas
prolonged hypoxia favors formation of cartilage or fibrous
tissue.19 In bone tissue engineering, vascularization is nec-
essary not only for new bone formation but also for the
survival of the implanted cells on the carrier material after
implantation.20 Accordingly, strategies that enhance angio-
genesis should have positive effects on bone repair.21
Most approaches to engineering new tissue relied on the
host for vascularization, but this is clearly not successful in
thick and highly vascularized tissues such as bone.22 Hence,
the need for proper vascularization, which involves the
creation of a microvascular network and a macroscopic
circulation, remains one of the major problems for larger
tissue-engineered structures.23 To create a vascularized
scaffold, a number of methods have been proposed.24,25
One approach involves the transplantation of ECs in an
effort to engineer a vascular network from these cells, rather
than waiting for host-blood-vessel ingrowth.26 However,
independently of the adopted approach to accelerate vas-
cularization, all of them will involve directly or indirectly
ECs. Therefore, the key success for vascularized bone is the
development of a structure that includes not only bone-
forming cells but also ECs.
We herein propose for the first time the use of combined
structures as a man-made equivalent of natural ECM for
bone tissue engineering. These constructs combine a macro
support, microfiber meshes made from a blend of starch with
polycaprolactone (SPCL), with a nano-network of electro-
spun type I collagen. These structures were designed en-
visioning formation of a mineralized matrix supplied by a
vascular network. Therefore, in this work we have charac-
terized the developed structures from the chemical and
structural point of view, and assessed the cellular responses
of bone-forming cells and ECs.
Materials and Methods
Materials
The material used in the production of microfiber meshes
was a SPCL blend (30/70w/w). More details on this mate-
rial can be found elsewhere.4,27
Collagen was isolated from Wistar rat tails according to a
typical acid extraction procedure.28 Briefly, the rat tails from
sacrificed animals were cut off and soaked in ethanol (70%)
for 1min. The tendons were then pulled out and dissolved in
sterile acetic acid (0.5M). The resulted solution was filtered
through a sterile muslin gauze and freeze-dried. All the re-
agents used were analytical grade unless specified otherwise.
Production of nano- and microfiber
combined structures
Wet spinning. Starch-based fiber meshes were fabricated
by wet spinning methodology as described elsewhere.4 In a
typical procedure, a viscous polymer solution was obtained
by dissolving SPCL in chloroform (40% w/v). Methanol was
used as a coagulant. A syringe pump (World Precision In-
struments) was used to extrude a certain amount of polymer
into a coagulation bath. The fiber mesh structure was formed
during the processing by moving of the coagulation bath
randomly. The fiber meshes were then dried at room tem-
perature (RT) overnight to remove remaining solvents.
Electrospinning. To obtain collagen nanofibers on the
wet-spun SPCL fiber meshes, an electrospinning method was
used. Collagen (0.85mg) was dissolved in 1mL of 1,1,1,3,3,3-
hexafluoro-2-propanol and thoroughly mixed until the dis-
solution completed. The polymer solution was put into a
syringe and placed in a syringe pump. A positive high-
voltage supplier was used to maintain the voltage at 20 kV.
The voltage was applied between the syringe tip and a
ground plate, where the fiber mesh membranes were placed,
during 10 s. Both sides of the membranes were impregnated
with collagen nanofibers. The final structures were then
dried overnight at RT to eliminate solvent residuals.
Crosslinking of the combined structures. The developed
constructs were crosslinked with saturated gluteraldehyde
vapor at RT for 48 h. The samples were placed on a metal
mesh and put inside a vacuum oven containing an aqueous
glutaraldehyde solution (30% v/v). After crosslinking, the
constructs were subsequently immersed in glycine solution
(0.02M) for 4 h to remove unreacted glutaraldehyde. They
were then washed several times with distilled water, dried,
and stored at dessicator until use.
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Design of thicker scaffolds using a layer-by-layer con-
cept. Although the thickness of the prepared membrane
allows to impregnate the microfiber meshes with nanofibers,
it would be more difficult to obtain a homogenous structure
when the thickness of the fiber meshes increases. To over-
come this problem, we propose in this work the use of a
layer-by-layer concept to design a thick scaffold with a ho-
mogenous nanofiber distribution, even in the interior part of
the scaffold. In this method, SPCL fiber mesh membranes
with one side deposited with collagen nanofibers were stack
together by simply heating at 608C, which is the melting
point of SPCL. The schematic illustration of this process is
presented in Figure 1.
Morphology of nano/micro combined scaffold
The morphology of the developed structures was ob-
served by a scanning electron microscope (SEM; Leica
Cambridge S360) and an optical microscope. The samples
were further examined by SEM to evaluate the influence of
crosslinking in the fiber morphology and overall structure.
Further and in a way to complement SEM data, the 3D
architecture of the collagen nano-network was assessed by
confocal laser scanning microscopy (CLSM; Olympus IX81)
after staining with antibody against type I collagen. The
scaffolds were incubated for 1 h at RT with the primary an-
tibody mouse anti-bovine (1:100; Sigma-Aldrich). After
phosphate-buffered saline (PBS) washing, a second incuba-
tion was performed for 1 h at RT with secondary antibody
anti-mouse Alexa Fluor 488 (1:100; Invitrogen). The con-
structs were washed with PBS, mounted with mounting
medium (Vectashield), and observed by CLSM (Olimpus
IX81).
Cells, culture conditions, and scaffolds seeding
A human osteoblast cell line (SaOs-2) was selected to test
the developed structures. The cells were cultured in com-
pleted medium Dulbecco’s modified Eagle’s medium low
glucose (Sigma-Aldrich) supplemented with 10% fetal bo-
vine serum (Sigma) and 1% antibiotics/antimicotics (Sigma-
Aldrich) until they reached the confluence. They were then
trypsinized and seeded onto the samples using the density of
2105 cells/scaffold. The cells on the combined structures
were allowed to grow for 7 days under standard conditions
(378C, 5% CO2).
Primary cultures of human endothelial cells (human um-
bilical vein endothelial cells [HUVECs]) were isolated from
the umbilical vein by collagenase digestion according to a
previously published method.29 HUVECs were cultured in
M199 medium (Sigma-Aldrich) supplemented with fetal calf
serum (20%; Gibco), antibiotics/antimicotics (1%), glutamax
I (2mM; Gibco), sodium heparin (25mg/mL; Sigma-Aldrich),
and ECs growth supplement (25 mg/mL; BD Biosciences).
Some of the combined structures were precoated with a fi-
bronectin solution (10 mg/mL PBS; Sigma-Aldrich) for 1 h at
378C. Confluent HUVECs were trypsinized and a suspension
of 7.5104 cells was added to each sample. The cell/sample
constructs were incubated under standard culture conditions
for 3 and 7 days.
Cell imaging
SEM was the chosen technique for an initial evaluation of
the morphology of the cells growing on the developed
scaffolds. Samples were fixed with glutaraldehyde in PBS
(2.5%) for 30min, dehydrated in increasing concentrations of
alcohol, air-dried, and sputter coated with gold before SEM
observation (Leica Cambridge S360).
The cellular viability was assessed through the vital dye
calcein-AM. Both osteoblast- and HUVEC-seeded combined
structures were incubated for 10min in the medium sup-
plemented with calcein-AM (0.1 mM). This vital dye is inter-
nalized by viable cells that by the action of active
intracellular esterases convert into a green fluorescent im-
permeable dye. Then samples were mounted in mounting
medium Vectorshield (Vector) and observed by CLSM
(Olimpus IX81).
Platelet–endothelial cell adhesion molecule-1
and phalloidin expression
Samples were fixed with a solution of formalin (3.7%;
Sigma) and permeabilized with Triton (0.1%) for 5min at RT.
The scaffolds cultured with HUVECs were stained for the
cell–cell adhesion molecule (platelet–endothelial cell adhe-
sion molecule-1 [PECAM-1]). For this, EC-seeded scaffolds
were incubated for 45min at RT with the primary antibody
mouse anti-human PECAM-1 (1:50; Dako). A second incu-
bation was performed with the secondary antibody anti-
mouse Alexa Fluor 488 for 45min at RT.
Actin fibers of both HUVECs and SaOs cells growing on
the scaffolds under analysis were observed by fluorescent
phalloidin. Fixed and permeabilized samples were incubated
for 20min with Alexa Fluor–conjugated phalloidin (1:80;
Sigma) at RT.
In both PECAM-1 and phalloidin staining experiments, the
nucleiwere counterstainedwith 40,6-diamidino-2-phenylindole
FIG. 1. Schematic illustration of layer-by-layer concept (thickness of the fiber mesh membranes is about 500 mm).
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(DAPI) (1:1000; Sigma) for 5min at RT. To remove the excess
of reagents between each step, a washing with PBS was al-
ways performed.
Cell proliferation assay
After 3 and 7 days of culture, cell proliferation was as-
sessed by means of measuring mitochondrial dehydrogenase
activity using Cell Titer 96 Aqueous One Solution Cell Pro-
liferation Assay kit (Promega), according to the manufacturer’s
protocol. This assay is based on the bioreduction of the sub-
strate, (3-(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-
2(4-sulphophenyl)-2H tetrazolium) (MTS), into a brown
formazan product by NADPH or NADP produced by de-
hydrogenase enzyme in metabolically active cells. According
to the standard procedure, the triplicates of the samples were
washedwith sterile PBS andplaced in new culturewells. Fresh
medium without phenol red and MTS reagent were added to
each well in 5/1 ratio. The reaction was carried out by incu-
bating the cell/scaffold constructs with this medium for 3 h at
378C in a humidified atmosphere containing 5% of CO2. In the
end of the reaction, incubated medium (100mL) was trans-
ferred to 96-well plate and optical density was read at 490nm
in a micro-plate reader (Synergy HT; Bio-tek). The results are
expressed as the average absorbance of triplicate samples.
Statistical analysis
All data related to MTS assay were reported
means standard deviation for n¼ 3 for each sample. Values
were analyzed by using a two-tailed student’s t-test and
p-values< 0.05 were considered significant.
Results
Morphology of the developed structures
Optical microscope image demonstrates the structural
organization of both nano- and microfiber networks in a
combined structure (Fig. 2A). SPCL microfibers with a
diameter of 100mm create a nonwoven mesh structure while
collagen nanofibers laid onto them with a random orienta-
tion. This structural organization can be seen more clearly by
SEM in Figure 2B. The average diameter of collagen nano-
fibers was measured to be around 400 nm. In addition, there
was no bead formation on the nanofibers, which indicates
that optimum experimental parameters for electrospinning
were used for this particular study.
The collagenous nature of the nanofibers in the combined
structures was assessed by immunohistochemistry with anti-
body raised against type I collagen (Fig. 2C). CLSM confirmed
the type I collagen nature of the nanofibers and disclosed their
spatial distribution on the combined structures. On the com-
bined structures type I collagen nanofibers were found on top
of the microfibers and spanning between them. Nanofibers
covering SPCL microfibers provided them with a type I
collagen coating. Between microfibers, randomly electrospun
nanofibers originated a branched network of type I collagen.
To maintain the structural and mechanical integrity,
scaffolds made of collagen should be crosslinked. There are
several methods that can be used for collagen crosslinking.
Herein, we applied chemical crosslinking strategy based on
the application of glutaraldehyde vapor. Using glutar-
aldeyhde in the vapor form would not only allow the
FIG. 2. Structural organization of the combined constructs
observed by (A) optical microscopy, 50, and (B) SEM. (C)
Immunostaining with antibody against type I collagen. (D)
Morphology of the structures after crosslinking with glutar-
aldehyde. SEM, scanning electron microscopy. Color images
available online at www.liebertonline.com/ten.
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crosslinker to penetrate into the deepest part of the samples,
but also will minimize the toxic effect of this reaction. It is
also important to note that glycine is used to remove un-
reacted glutaraldehyde. It has been reported that amino
groups of glycine can react easily with the aldehyde groups
that are come from unreacted gluteraldeyde.30 After cross-
linking, it is important to analyze the effect of the reaction on
the morphology of the collagen nanofibers, as well as on the
integrity of the overall scaffold structure. As it is presented in
Figure 2D, crosslinking process had no side effect on the
nanofiber morphology and the combined structures retained
their structural integrity as before crosslinking.
Figure 1 shows a schematic illustration of thick combined
scaffolds prepared by means of using the layer by layer
concept. SEM analysis indicated that collagen nanofibers
distributed homogenously overall scaffold, including the
interior part. Moreover, both micro and nanofiber meshes
were able to maintain their original structural organizations
in the same construct even after the mild heating process and
create a thicker scaffold.
Osteoblast cell attachment and proliferation
The viability of the osteoblasts seeded on the combined
structures was visually determined by calcein-AM staining
and by its conversion into a green fluorescent and imper-
meable product by esterases of viable cells. After 3 days of
culture, cells could attach and cover both nano- and micro-
fibers of the combined structures (Fig. 3A). They were able to
bridge between SPCL microfibers by using collagen nanofi-
bers. The influence of nanofibers on the cell morphology can
be seen better in the SEM image (Fig. 3B). In the presence of
nanofibers, osteoblast were stretching themselves along the
nanofibers and making bridges between microfibers. This
morphological change of the cells led a different cytoskeleton
pattern as it was observed by phalloidin staining (Fig. 3C).
Cell proliferation was followed by an MTS assay for 7 days
(Fig. 3D). Cell proliferation increased form days 3 to 7 for
both control (samples without collagen nanofibers) and
combined scaffolds. Compared to the cell proliferation in the
presence of nanofibers, metabolic activity of the cells was
significantly ( p< 0.05) higher for all time period tested.
EC attachment and metabolic activity
On what concerns to ECs, cell adhesion was assessed in
the absence and presence of fibronectin as a precoating.
Currently available polymeric materials do not generally
support EC growth without coating with adhesive proteins,
such as fibronectin; therefore, this was used as a positive con-
trol. After 3 days of culture both noncoated and fibronectin-
coated combined structures were covered by viable ECs
FIG. 3. Osteoblast-like cells on the combined structures
after 3 days of culture. (A) Confocal microscopy of osteo-
blasts after staining with the vital dye calcein-AM. (B) SEM
images of osteoblasts on the developed structures. (C) Phal-
loidin staining of osteoblasts seeded on combined structures.
Nuclei were counterstained with 40,6-diamidino-2-pheny-
lindole (DAPI) and the immunofluorescent micrographs were
obtained by confocal microscopy. Original magnification:100
(D) Proliferation of osteoblasts was determined by MTS assay.
Color images available online at www.liebertonline.com/ten.
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(Fig. 4A, B). SEM data revealed flat and spread ECs on the
nano-network and arranged in circular structures (Fig. 4C), an
arrangement quite distinct from that observed for the osteo-
blasts. A higher magnification unveiled not only that ECs are
growing on top of type I collagen nanofibers but also that these
nanofibers are being integrated into the cellular cytoplasma
(Fig. 4D). When analyzing the effect of precoating the scaffold
with fibronectin, it was observed the same cell adhesion pat-
tern and cell morphology in the absence of coating. MTS data
further support these finding insofar as after 3 and 7 days there
was not observed any significant difference in the of ECs
growing on fibronectin-coated and noncoated combined
structures (Fig. 4E).
Cell morphology of ECs growing on noncoated and
fibronectin-coated combined structures was further unveiled
after actin cytoskeleton staining with phalloidin. On the
nano-network ECs’ cytoskeleton followed the alignment
dictated by type I collagen nanofibers (Fig. 5A). One should
particularly note that there are single cells growing on the
individual nanofibers with their actin filaments directed in a
unidirectional way. When looking at the positive control,
scaffolds precoated with fibronectin, no difference was ob-
served in the pattern of cytoskeleton in relation to nano-/
microfiber combined scaffold without coating (Fig. 5B).
Expression of the cell junction PECAM-1, the major hall-
mark of the endothelia, was assessed by immunohisto-
FIG. 4. HUVECs on the combined structures after 3 days of culture and the influence of fibronectin precoating on viability,
morphology, and proliferation; (A, C, D) noncoated constructs and (B, E) precoated with fibronectin. Confocal microscopy of
HUVECs after staining with the vital dye calcein-AM (A, B). SEM images of HUVECs on the developed structures (C–E).
Proliferation of HUVECs was determined by MTS assay (F). Scale bar: (A, B) 200mm. HUVECs, human umbilical vein
endothelial cells. Color images available online at www.liebertonline.com/ten.
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chemistry and observed by CLSM. ECs growing on the
combined structures were able to express PECAM-1 at cell–
cell borders (Fig. 5C). Expression of this important molecule
was observed both on micro- and nanofibers. Once more,
fibronectin coating was not required for the endothelial
phenotype of ECs on the developed combined structures and
the same PECAM-1 staining between adjacent cells was ob-
served in the two conditions under study (Fig. 5C, D).
Discussion
Wet-spun microfiber meshes made of SPCL polymeric
blend and electrospun nanofibers from collagen were joined
into the same construct, giving rise to combined structures.
For that, a two-step methodology was used, a concept and
technology previously developed and reported by Tuzla-
koglu et al.31,32 This new construct is proposed as a man-
made equivalent of ECM, which could mimic the physical
and chemical structure of it. SPCL microfiber meshes con-
stitute the macro support for the cells, whereas collagen
nanofibers laid on them aim to mimic the collagen fibrils of
natural ECM. The role of long and stiff collagen fibrils in
ECM is to serve structural support as well as connecting and
recognition function between cells and the matrix.10 Collagen
has maintained a highly conserved aminoacids sequence that
provides binding sites for integrins presented in cell mem-
branes. In fact, integrin binding is a key factor for the nec-
essary cell–ECM communication that is lacking when
synthetic polymers are used.33 Besides the above-mentioned
importance, the choice of collagen relays in the fact that is the
most abundant protein within the natural ECM.
To evaluate the structural similarity of the developed
combined structures to natural ECM, we used optical and
scanning electron microscopy observation. Further, confocal
microscopy was selected to assess and observe collagen na-
nofibers, which were supposed to play a role in chemically
mimicking besides the structural one. Structures prepared
from micro- and nanofibers demonstrated an architecture
with randomly distributed nanofibers that matches the one
in the natural ECM.10 In electrospinning experiments, pro-
cessing conditions, particularly processing time, were opti-
mized to create nanofibers in appropriate deposition amount
and size. The optimum used conditions were resulted in a
random deposition of nanofibers on the microfiber meshes.
The average diameter of nanofibers was around 400 nm,
which coincides well with the collagen fiber bundle diameter
characteristic of the natural ECM.34 Immunohistochemistry
results confirmed the collagenous nature of nanofibers that
were deposited on SPCL microfiber meshes.
The present article introduces the layer-by-layer concept, a
novel approach that we have developed to be able to design
a structure resembling natural ECM, but that simultaneously
FIG. 5. Phalloidin (A, B)
and platelet–endothelial cell
adhesion molecule-1 staining
(C, D) of HUVECs seeded on
combined structures noncoated
(A, C) and fibronectin coated
(B, D). Nuclei were counter-
stained with DAPI and the
immunofluorescent micro-
graphs were obtained by
confocal microscopy. Original
magnification:100. Color
images available online at
www.liebertonline.com/ten.
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takes into account the needs for real clinical applications.
This rather simple method allowed us to create a construct
with a requested thickness for implantation, by means of
combining several microfiber meshes with homogenously
distributed nanofibers in a single scaffolding material.
The structural merits of developed constructs were eval-
uated by assessing cellular responses of two important cell
types in bone repair (osteoblasts and endothelial) and their
viability, cytoskeleton, and expression markers. Data pub-
lished in this study clearly demonstrated that osteoblast-like
cells cultured on the combined structures were able to stretch
themselves along the nanofibers, while maintaining their
typical spindle-like morphology on the microfibers. The
surface of SPCL microfibers was also covered by collagen
nanofibers as it was observed by SEM analysis. With respect
to this indication, we can claim that the morphological
changes of osteoblasts were influenced not only by the che-
mical nature of the material but also by its the structural
organization.
The effect of nano-/microfiber combination on cell via-
bility and metabolic activity was screened using an MTS
assay. The presence of collagen nanofibers in the structure
resulted in an increase of metabolic activity and growth
rate when directly compared to a scaffold without nanofi-
bers. Similar results were previously reported with SaOs-2
and rat bone marrow stromal cells in culture on nano- and
micro-combined structure made of SPCL.31 Previous re-
ports have demonstrated that type I collagen enhances bone
cell viability and growth.35,36 It has been used to coat me-
tallic implant to enhance osteoblast spreading that results in
a more rapid formation of focal adhesions and their asso-
ciated stress fibers.37,38 Our results suggest that the pres-
ence of type I collagen nanofibers appears to influence the
cell viability of the osteoblast-like cells cultured on the de-
veloped structures. Besides the chemical influence of col-
lagen, the previously deposited nanofibers reduce large
void spaces between microfibers and create larger surface
area that the cells can adhere from the very beginning. With
respect to this phenomenon, the presence of collagen na-
nofibers in the constructs initially clearly increases the cell
seeding efficiency and later on results in a higher cellular
metabolic activity.
Cellular adhesion, spreading, and migration is known to
be dependent on its cytoskeleton system, including actin
filaments.39 The cytoskeletal organization of the cells also
ordinates the morphological organization of ECM. Therefore,
we performed fluorescent phalloidin staining to observe
actin filaments in the cytoskeleton of the cells. A clear dif-
ference in actin filaments was observed between the cells
growing on the microfibers and the nanofibers. Due to the
effect of collagen nanofibers, cytoskeleton of the cells grow-
ing on nanofibers showed more elongated shape than the
one growing on microfibers. Since the cell shape is modu-
lated by polymerization of actin filaments, these results can
explain the morphological changes of osteoblast growing on
nanofibers, which was observed by SEM.
Presently, one of the major hurdles in the clinical appli-
cation of tissue engineering to repair metabolically de-
manding tissues (e.g., bone) is the absence of a capillary bed
linking the construct to the host blood system.40 Due to their
active role in angiogenesis, ECs are a key cell type.41 Besides
that, ECs are pivotal members of a complex interactive
communication network in bone.42 Therefore, the chemical
composition as well as architecture of combined structures
was designed envisioning not only bone-forming cells but
also ECs. Type I collagen, together with SPCL, is one of the
building blocks of this scaffold and is the major constituent
of the extracellular matrices to which proliferating ECs are
exposed in injured tissue.43 Moreover, collagen also provides
adhesive support for osteoblasts, as it has been discussed
above.44 Therefore, one of the objectives of including a nano-
network of type I collagen was not only to supply a nano-
range physical support for cells but also to provide a cell
adhesion promoter. This last aspect is especially important
for ECs once they are very demanding and dependent in
terms of substrate adhesion. Normally, a very common
procedure to improve EC adhesion to the substrate is a
precoating with molecules from ECM such as fibronectin.45–47
In this work we evaluated the ability of the combined
structures to support the growth of ECs without the re-
quirement of any additional precoating. As a positive control
the scaffolds were precoated with fibronectin. ECs adhered
to uncoated combined structures, remained viable, and ex-
hibited a flat and stretch morphology. The same cell adhe-
sion pattern and cellular morphology were observed for
combined structures with fibronectin coating. Metabolic ac-
tivity quantification of ECs further supported the fact that
no significant difference was observed between the positive
control and uncoated combined structures. These overall
results indicate that precoating with fibronectin did not
further improve cell adhesion, viability, or influenced cell
morphology.
Angiogenesis is a complex phenomenon with multiple
progressive steps toward the end point of new blood vessels
formation. It starts with cell adhesion to the new substratum,
passing by migration, proliferation, organization in tube-like
structures, and deposition of new basement membrane;
all these steps have as a common denominator type I colla-
gen.44,48 On the nano-network of the developed constructs
ECs organized into circular structures resembling the
microcapillary-like structures formed during angiogenesis.
Also, of particular interest is the intimate contact that was
established between ECs and collagen nanofibers. As ob-
served by SEM, nanofibers were integrated within cellular
cytoplasma. It has long been recognized that 3D interstitial
collagen type I provokes ECs in culture to undergo marked
shape changes that closely imitate the cord-like structures
observed during adult angiogenesis. This behavior is EC
specific, and this may explain why osteoblasts did not exhibit
the same morphology and 3D arrangement on the combined
structures.
Regarding ECs’ cytoskeleton, phalloidin staining revealed
different patterns on the combined structures. On nanofibers
the cells were more stretched and with actin filaments
aligned in an un-directional way, in contrast to microfibers
where cells exhibit a more disperse conformation of actin
fibrils. These differences reflex the distinct biochemical and
physiochemical natures of the substrata on the combined
structures, which ultimately will dictate diverse cell func-
tions such as migration, proliferation, among others.10
ECs’ migration is an important factor for angiogenesis,
particularly during sprouting of new blood vessels from the
existing vasculature.44 The inclusion of the nano-network
was also designed to increment ECs’ motility. This was
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based on data indicating that ECs are most motile in sparse
culture in which they establish few contacts with their
neighbors, in opposition to cells incorporated into a conflu-
ent monolayer that reveal reduced movements.49,50 There-
fore, it is expected that when exposed to an angiogenic
environment, ECs on the different fiber size of the combined
structure will behave differently; sparse ECs on nanofibers
will be more motile than confluent cells lying down on mi-
crofibers. Also, the collagenous nature of the nano-network
will probably contribute to this motility. This assumption is
in keeping with in vitro studies that have shown that type I
collagen not only supports chemotactic migration of ECs but
is also responsible for haptotactic migration.44
For vessel formation, networking and remodeling cell–cell
adhesion are particularly important.50 PECAM-1 is a cell
adhesion molecule, concentrated at the lateral junctions of
adjacent ECs and is a major hallmark of the endothelium. On
the combined structures, ECs contacted with their neighbor
cells and expressed PECAM-1 at the borders. PECAM-1
staining was present on the overall structure, indicating that
the effect of micro- and nanometric fiber size did not affect
cell–cell communication. These findings confirm the normal
endothelial phenotype, being also a good indicator of the
interactions between ECs and the novel combined structures.
Conclusions
We developed combined structures as a new construct
nature-inspired that recreates the physical and chemical en-
vironment of bone matrix. These structures were obtained by
a two-step methodology where nanofibers of type I collagen,
with an average size of 400 nm, were electrospun on the
macro support made from SPCL fiber mesh. The collagenous
nature of the nano-network was confirmed by im-
munhistochemistry and its 3D architecture characterized by
several microscopy techniques. Further, it was proved the
efficacy of the layer-by-layer concept as an approach to cre-
ate thicker scaffolds.
Regarding cellular interactions, combined structures were
able to support the adhesion and growth of both osteoblasts
and ECs. About osteoblasts, the presence of type I collagen
nanofibers increased metabolic activity and the surface area
available for cell spanning. In the particular case of ECs, the
inclusion of type I collagen obviated the need of precoating
with fibronectin and cells organized into circular structures
resembling angiogenic organization.
Our findings indicate that combined structures are an
appropriate human equivalent of natural ECM for bone tis-
sue engineering.
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